Mark Thompson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In Crigler-Najjar type II patients and, recently, in Crigler-Najjar type I patients treated with human hepatocyte cell therapy, phenobarbital has been used for reducing the serum bilirubin load. Its(More)
OBJECTIVE High altitude headache (HAH) is the most common neurological complaint at altitude and the defining component of acute mountain sickness (AMS). However, there is a paucity of literature(More)